1 | together | 8,142 |
2 | conjointly | 10 |
3 | 5a-f | 9 |
4 | coincidently | 9 |
5 | hand-in-hand | 7 |
6 | 'randomization | 5 |
7 | trendwise | 5 |
8 | 1a-c | 4 |
9 | chaperonins | 4 |
10 | clashed | 4 |
11 | foiled | 4 |
12 | 3+4=7 | 3 |
13 | 3-phenylpropanoids | 3 |
14 | alkalitolerant | 3 |
15 | co-morbidly | 3 |
16 | cμ | 3 |
17 | dedifferentiate | 3 |
18 | herpv | 3 |
19 | hypercapnoea | 3 |
20 | l4l5 | 3 |
21 | liqueurs | 3 |
22 | nasality | 3 |
23 | overconcern | 3 |
24 | periconceptionally | 3 |
25 | +3010c/g | 2 |
26 | 1-n | 2 |
27 | 1-sepsis | 2 |
28 | 2,3-diaryl-indoles | 2 |
29 | 25-norhopanes | 2 |
30 | 2a/b | 2 |
31 | 3-t-butyl-4-hydroxyanisole | 2 |
32 | 4.7°c | 2 |
33 | 5,7,4'-trihydroxy-6-methoxyflavone | 2 |
34 | 64k | 2 |
35 | 9a-c | 2 |
36 | bactofection | 2 |
37 | bpd-tg | 2 |
38 | cbz-avlq-cn | 2 |
39 | cd34+/cd38- | 2 |
40 | crystallises | 2 |
41 | cyp716y1 | 2 |
42 | euphemisms | 2 |
43 | formylation | 2 |
44 | gln275 | 2 |
45 | gw7845 | 2 |
46 | helpfully | 2 |
47 | hp-5 | 2 |
48 | imidazolo- | 2 |
49 | immuno-enrichment | 2 |
50 | mn0.24 | 2 |
51 | nd199 | 2 |
52 | neurolupus | 2 |
53 | quadriplegia/paraplegia | 2 |
54 | r=-0.233 | 2 |
55 | self-affirm | 2 |
56 | treadmillometry | 2 |
57 | wscore | 2 |
58 | α4-α6 | 2 |
59 | γ-lactams | 2 |
60 | *rice | 1 |
61 | /ala/ | 1 |
62 | 18-55-year-olds | 1 |
63 | 3,5-dinitro-1,2,4-triazolates | 1 |
64 | 4,4-diphenyl-2-azabuta-1,3-dienes | 1 |
65 | 4-oxothiazolidines | 1 |
66 | acompared | 1 |
67 | acorit | 1 |
68 | alone.importantly | 1 |
69 | aminosilanes | 1 |
70 | amoxiicillin | 1 |
71 | ankle-foot-orthoses | 1 |
72 | anticoagaulation | 1 |
73 | antiretroviralprophylaxis | 1 |
74 | bank-a-trial | 1 |
75 | bismurrayafoline-a | 1 |
76 | cfna | 1 |
77 | chemosaturation | 1 |
78 | chronics | 1 |
79 | compound-sweeteners | 1 |
80 | conclusions-pe | 1 |
81 | confusedly | 1 |
82 | conjunctivodacryorhinostomy | 1 |
83 | co‑treatment | 1 |
84 | cross-calibration | 1 |
85 | crosswise | 1 |
86 | duodenectomy | 1 |
87 | failure-times | 1 |
88 | failure/switching | 1 |
89 | ferrand | 1 |
90 | fl/d3 | 1 |
91 | fluvastatin-combined | 1 |
92 | for-math | 1 |
93 | friedman's-non-parametric-test | 1 |
94 | genotype-agroup | 1 |
95 | gingerly | 1 |
96 | hazard-associated | 1 |
97 | helicoid | 1 |
98 | hexachlorobenzenes | 1 |
99 | humorously | 1 |
100 | hvhsp16.88-ci | 1 |
101 | hydrodelamination | 1 |
102 | hypercastration | 1 |
103 | hysteroskopy | 1 |
104 | isobavachalcone | 1 |
105 | juxtasomally | 1 |
106 | leukaphereses | 1 |
107 | lock-therapy | 1 |
108 | loretense | 1 |
109 | mastermixes | 1 |
110 | measurement/evaluation | 1 |
111 | mtf+nac=treated | 1 |
112 | mtf=treated | 1 |
113 | multi-sample-analyses | 1 |
114 | myoepitheliomas | 1 |
115 | needle-washout | 1 |
116 | neuroleptoanalgesia | 1 |
117 | ngcbs | 1 |
118 | noncirrhotics | 1 |
119 | obscurior | 1 |
120 | ogygia | 1 |
121 | oleandrine | 1 |
122 | over-the-counters | 1 |
123 | paitents | 1 |
124 | phonomecanography | 1 |
125 | place.this | 1 |
126 | placebo/sugammadex | 1 |
127 | postdance | 1 |
128 | pre-rinsing | 1 |
129 | prefused | 1 |
130 | semi-structured-interviews | 1 |
131 | sonocatalysts | 1 |
132 | sparticipants | 1 |
133 | sr/sr | 1 |
134 | stablon® | 1 |
135 | sub-responses | 1 |
136 | synergestically | 1 |
137 | syringe/needles | 1 |
138 | themes-coping | 1 |
139 | thermosymmetry | 1 |
140 | ti4+ | 1 |
141 | trende | 1 |
142 | twcawe | 1 |
143 | unopen | 1 |
144 | up/night | 1 |
145 | z0996 | 1 |
1 | 'randomization | 5 |
2 | *rice | 1 |
3 | +3010c/g | 2 |
4 | /ala/ | 1 |
5 | 1-n | 2 |
6 | 1-sepsis | 2 |
7 | 18-55-year-olds | 1 |
8 | 1a-c | 4 |
9 | 2,3-diaryl-indoles | 2 |
10 | 25-norhopanes | 2 |
11 | 2a/b | 2 |
12 | 3+4=7 | 3 |
13 | 3,5-dinitro-1,2,4-triazolates | 1 |
14 | 3-phenylpropanoids | 3 |
15 | 3-t-butyl-4-hydroxyanisole | 2 |
16 | 4,4-diphenyl-2-azabuta-1,3-dienes | 1 |
17 | 4-oxothiazolidines | 1 |
18 | 4.7°c | 2 |
19 | 5,7,4'-trihydroxy-6-methoxyflavone | 2 |
20 | 5a-f | 9 |
21 | 64k | 2 |
22 | 9a-c | 2 |
23 | acompared | 1 |
24 | acorit | 1 |
25 | alkalitolerant | 3 |
26 | alone.importantly | 1 |
27 | aminosilanes | 1 |
28 | amoxiicillin | 1 |
29 | ankle-foot-orthoses | 1 |
30 | anticoagaulation | 1 |
31 | antiretroviralprophylaxis | 1 |
32 | bactofection | 2 |
33 | bank-a-trial | 1 |
34 | bismurrayafoline-a | 1 |
35 | bpd-tg | 2 |
36 | cbz-avlq-cn | 2 |
37 | cd34+/cd38- | 2 |
38 | cfna | 1 |
39 | chaperonins | 4 |
40 | chemosaturation | 1 |
41 | chronics | 1 |
42 | clashed | 4 |
43 | co-morbidly | 3 |
44 | coincidently | 9 |
45 | compound-sweeteners | 1 |
46 | conclusions-pe | 1 |
47 | confusedly | 1 |
48 | conjointly | 10 |
49 | conjunctivodacryorhinostomy | 1 |
50 | co‑treatment | 1 |
51 | cross-calibration | 1 |
52 | crosswise | 1 |
53 | crystallises | 2 |
54 | cyp716y1 | 2 |
55 | cμ | 3 |
56 | dedifferentiate | 3 |
57 | duodenectomy | 1 |
58 | euphemisms | 2 |
59 | failure-times | 1 |
60 | failure/switching | 1 |
61 | ferrand | 1 |
62 | fl/d3 | 1 |
63 | fluvastatin-combined | 1 |
64 | foiled | 4 |
65 | for-math | 1 |
66 | formylation | 2 |
67 | friedman's-non-parametric-test | 1 |
68 | genotype-agroup | 1 |
69 | gingerly | 1 |
70 | gln275 | 2 |
71 | gw7845 | 2 |
72 | hand-in-hand | 7 |
73 | hazard-associated | 1 |
74 | helicoid | 1 |
75 | helpfully | 2 |
76 | herpv | 3 |
77 | hexachlorobenzenes | 1 |
78 | hp-5 | 2 |
79 | humorously | 1 |
80 | hvhsp16.88-ci | 1 |
81 | hydrodelamination | 1 |
82 | hypercapnoea | 3 |
83 | hypercastration | 1 |
84 | hysteroskopy | 1 |
85 | imidazolo- | 2 |
86 | immuno-enrichment | 2 |
87 | isobavachalcone | 1 |
88 | juxtasomally | 1 |
89 | l4l5 | 3 |
90 | leukaphereses | 1 |
91 | liqueurs | 3 |
92 | lock-therapy | 1 |
93 | loretense | 1 |
94 | mastermixes | 1 |
95 | measurement/evaluation | 1 |
96 | mn0.24 | 2 |
97 | mtf+nac=treated | 1 |
98 | mtf=treated | 1 |
99 | multi-sample-analyses | 1 |
100 | myoepitheliomas | 1 |
101 | nasality | 3 |
102 | nd199 | 2 |
103 | needle-washout | 1 |
104 | neuroleptoanalgesia | 1 |
105 | neurolupus | 2 |
106 | ngcbs | 1 |
107 | noncirrhotics | 1 |
108 | obscurior | 1 |
109 | ogygia | 1 |
110 | oleandrine | 1 |
111 | over-the-counters | 1 |
112 | overconcern | 3 |
113 | paitents | 1 |
114 | periconceptionally | 3 |
115 | phonomecanography | 1 |
116 | place.this | 1 |
117 | placebo/sugammadex | 1 |
118 | postdance | 1 |
119 | pre-rinsing | 1 |
120 | prefused | 1 |
121 | quadriplegia/paraplegia | 2 |
122 | r=-0.233 | 2 |
123 | self-affirm | 2 |
124 | semi-structured-interviews | 1 |
125 | sonocatalysts | 1 |
126 | sparticipants | 1 |
127 | sr/sr | 1 |
128 | stablon® | 1 |
129 | sub-responses | 1 |
130 | synergestically | 1 |
131 | syringe/needles | 1 |
132 | themes-coping | 1 |
133 | thermosymmetry | 1 |
134 | ti4+ | 1 |
135 | together | 8,142 |
136 | treadmillometry | 2 |
137 | trende | 1 |
138 | trendwise | 5 |
139 | twcawe | 1 |
140 | unopen | 1 |
141 | up/night | 1 |
142 | wscore | 2 |
143 | z0996 | 1 |
144 | α4-α6 | 2 |
145 | γ-lactams | 2 |
1 | ti4+ | 1 |
2 | cd34+/cd38- | 2 |
3 | imidazolo- | 2 |
4 | /ala/ | 1 |
5 | cyp716y1 | 2 |
6 | r=-0.233 | 2 |
7 | fl/d3 | 1 |
8 | mn0.24 | 2 |
9 | hp-5 | 2 |
10 | gw7845 | 2 |
11 | gln275 | 2 |
12 | l4l5 | 3 |
13 | z0996 | 1 |
14 | α4-α6 | 2 |
15 | 3+4=7 | 3 |
16 | nd199 | 2 |
17 | bismurrayafoline-a | 1 |
18 | hypercapnoea | 3 |
19 | quadriplegia/paraplegia | 2 |
20 | ogygia | 1 |
21 | neuroleptoanalgesia | 1 |
22 | cfna | 1 |
23 | 2a/b | 2 |
24 | 1a-c | 4 |
25 | 9a-c | 2 |
26 | 4.7°c | 2 |
27 | clashed | 4 |
28 | foiled | 4 |
29 | fluvastatin-combined | 1 |
30 | acompared | 1 |
31 | prefused | 1 |
32 | mtf+nac=treated | 1 |
33 | mtf=treated | 1 |
34 | hazard-associated | 1 |
35 | helicoid | 1 |
36 | hand-in-hand | 7 |
37 | ferrand | 1 |
38 | *rice | 1 |
39 | postdance | 1 |
40 | trende | 1 |
41 | 3-t-butyl-4-hydroxyanisole | 2 |
42 | oleandrine | 1 |
43 | isobavachalcone | 1 |
44 | 5,7,4'-trihydroxy-6-methoxyflavone | 2 |
45 | conclusions-pe | 1 |
46 | wscore | 2 |
47 | trendwise | 5 |
48 | crosswise | 1 |
49 | loretense | 1 |
50 | dedifferentiate | 3 |
51 | twcawe | 1 |
52 | 5a-f | 9 |
53 | +3010c/g | 2 |
54 | failure/switching | 1 |
55 | themes-coping | 1 |
56 | pre-rinsing | 1 |
57 | bpd-tg | 2 |
58 | for-math | 1 |
59 | hvhsp16.88-ci | 1 |
60 | 64k | 2 |
61 | bank-a-trial | 1 |
62 | self-affirm | 2 |
63 | 1-n | 2 |
64 | cbz-avlq-cn | 2 |
65 | unopen | 1 |
66 | amoxiicillin | 1 |
67 | anticoagaulation | 1 |
68 | formylation | 2 |
69 | hydrodelamination | 1 |
70 | cross-calibration | 1 |
71 | hypercastration | 1 |
72 | chemosaturation | 1 |
73 | measurement/evaluation | 1 |
74 | 'randomization | 5 |
75 | bactofection | 2 |
76 | overconcern | 3 |
77 | genotype-agroup | 1 |
78 | together | 8,142 |
79 | obscurior | 1 |
80 | sr/sr | 1 |
81 | myoepitheliomas | 1 |
82 | ngcbs | 1 |
83 | chronics | 1 |
84 | noncirrhotics | 1 |
85 | 3-phenylpropanoids | 3 |
86 | 18-55-year-olds | 1 |
87 | syringe/needles | 1 |
88 | 2,3-diaryl-indoles | 2 |
89 | failure-times | 1 |
90 | aminosilanes | 1 |
91 | 25-norhopanes | 2 |
92 | 4,4-diphenyl-2-azabuta-1,3-dienes | 1 |
93 | hexachlorobenzenes | 1 |
94 | 4-oxothiazolidines | 1 |
95 | leukaphereses | 1 |
96 | crystallises | 2 |
97 | sub-responses | 1 |
98 | ankle-foot-orthoses | 1 |
99 | multi-sample-analyses | 1 |
100 | 3,5-dinitro-1,2,4-triazolates | 1 |
101 | mastermixes | 1 |
102 | place.this | 1 |
103 | 1-sepsis | 2 |
104 | antiretroviralprophylaxis | 1 |
105 | γ-lactams | 2 |
106 | euphemisms | 2 |
107 | chaperonins | 4 |
108 | compound-sweeteners | 1 |
109 | over-the-counters | 1 |
110 | liqueurs | 3 |
111 | sparticipants | 1 |
112 | paitents | 1 |
113 | sonocatalysts | 1 |
114 | neurolupus | 2 |
115 | semi-structured-interviews | 1 |
116 | up/night | 1 |
117 | acorit | 1 |
118 | alkalitolerant | 3 |
119 | immuno-enrichment | 2 |
120 | co‑treatment | 1 |
121 | friedman's-non-parametric-test | 1 |
122 | needle-washout | 1 |
123 | herpv | 3 |
124 | placebo/sugammadex | 1 |
125 | phonomecanography | 1 |
126 | confusedly | 1 |
127 | co-morbidly | 3 |
128 | synergestically | 1 |
129 | juxtasomally | 1 |
130 | periconceptionally | 3 |
131 | helpfully | 2 |
132 | gingerly | 1 |
133 | humorously | 1 |
134 | alone.importantly | 1 |
135 | coincidently | 9 |
136 | conjointly | 10 |
137 | duodenectomy | 1 |
138 | conjunctivodacryorhinostomy | 1 |
139 | lock-therapy | 1 |
140 | hysteroskopy | 1 |
141 | thermosymmetry | 1 |
142 | treadmillometry | 2 |
143 | nasality | 3 |
144 | stablon® | 1 |
145 | cμ | 3 |